Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Family Medicine
Arrhythmia Clinical Trials
A listing of Arrhythmia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham :
4968 Post-approval Study
Birmingham : University of Alabama at Birmingham
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Birmingham :
nEw3 Post-approval Study
Alaska
Anchorage :
4968 Post-approval Study
Anchorage :
nEw3 Post-approval Study
Arizona
Gilbert :
nEw3 Post-approval Study
Phoenix :
4968 Post-approval Study
Scottsdale :
4968 Post-approval Study
Scottsdale :
nEw3 Post-approval Study
Arkansas
Jonesboro :
nEw3 Post-approval Study
Little Rock :
4968 Post-approval Study
Little Rock : Arkansas Cardiology, PA Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Little Rock :
nEw3 Post-approval Study
California
Bakersville :
4968 Post-approval Study
Bakersville :
nEw3 Post-approval Study
Chula Vista :
4968 Post-approval Study
Chula Vista :
nEw3 Post-approval Study
Downey :
4968 Post-approval Study
View More »
Downey :
nEw3 Post-approval Study
East Palo Alto :
4968 Post-approval Study
East Palo Alto :
nEw3 Post-approval Study
La Jolla :
nEw3 Post-approval Study
Long Beach :
nEw3 Post-approval Study
Los Angeles :
4968 Post-approval Study
Los Angeles : Good Samaritan Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Los Angeles :
nEw3 Post-approval Study
Orange : Orange County Heart Institute and Research Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Redding :
nEw3 Post-approval Study
Salinas :
4968 Post-approval Study
Salinas :
nEw3 Post-approval Study
San Diego : University of California San Diego Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
San Diego :
nEw3 Post-approval Study
San Francisco : University of California at San Francisco Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Santa Rosa :
nEw3 Post-approval Study
Stanford : Stanford University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Tarzana : Heart Rythm Specialists of Southern California Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Torrance :
4968 Post-approval Study
Torrance :
nEw3 Post-approval Study
Van Nuys :
4968 Post-approval Study
Van Nuys :
nEw3 Post-approval Study
Colorado
Aurora : The Medical Center of Aurora Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Colorado Springs :
4968 Post-approval Study
Colorado Springs : Penrose Saint Francis Health Services Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Colorado Springs :
nEw3 Post-approval Study
Denver :
4968 Post-approval Study
View More »
Denver :
nEw3 Post-approval Study
Connecticut
Hartford : Hartford Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Hartford : Hartford Hospital
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
Delaware
Newark :
nEw3 Post-approval Study
District of Columbia
Washington :
4968 Post-approval Study
Washington :
nEw3 Post-approval Study
Washington, D.C. : George Washington University Medical Faculty Associates Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Florida
Bradenton :
nEw3 Post-approval Study
Clearwater :
4968 Post-approval Study
Clearwater :
nEw3 Post-approval Study
Jacksonville :
4968 Post-approval Study
Jacksonville :
nEw3 Post-approval Study
View More »
Kissimmee : Osceola Regional Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Melbourne :
4968 Post-approval Study
Melbourne :
nEw3 Post-approval Study
Ocala :
4968 Post-approval Study
Orlando : Florida Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
St. Petersburg : Northside Hospital and Heart Institute Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Tallahassee : Tallahassee Memorial Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Tampa : Florida Heart Rhythm-University of South Florida College of Medicine Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Tampa :
nEw3 Post-approval Study
Wellington :
4968 Post-approval Study
Georgia
Albany :
nEw3 Post-approval Study
Atlanta :
4968 Post-approval Study
Atlanta :
nEw3 Post-approval Study
Augusta : Georgia Health Sciences University Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Columbus :
4968 Post-approval Study
View More »
Columbus :
nEw3 Post-approval Study
Macon : Georgia Arrhythmia Consultants & Research Institute Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Marietta :
4968 Post-approval Study
Marietta :
nEw3 Post-approval Study
Illinois
Barrington : Alexian Brothers Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Chicago : Rush University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Downers Grove : Advocate Good Samaritan Hospital
Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Implantable Cardioverter Defibrillators
Evanston : NorthShore University Health System Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Maywood : Loyola University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
View More »
Naperville : Edward Hospital
Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Implantable Cardioverter Defibrillators
Oak Lawn :
4968 Post-approval Study
Oak Lawn :
nEw3 Post-approval Study
Indiana
Evansville :
nEw3 Post-approval Study
Indianapolis :
4968 Post-approval Study
Indianapolis : Saint Vincent Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Indianapolis :
nEw3 Post-approval Study
Newburgh :
4968 Post-approval Study
Iowa
Des Moines :
4968 Post-approval Study
Des Moines :
nEw3 Post-approval Study
West Des Moines : Mercy Medical Center-Iowa Heart Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Kansas
Kansas City :
4968 Post-approval Study
Kansas City :
nEw3 Post-approval Study
Kentucky
Edgewood :
nEw3 Post-approval Study
Lexington :
4968 Post-approval Study
Lexington : Central Baptist Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Lexington :
nEw3 Post-approval Study
Louisville :
4968 Post-approval Study
View More »
Louisville :
nEw3 Post-approval Study
Louisiana
Alexandria :
4968 Post-approval Study
Alexandria :
nEw3 Post-approval Study
Baton Rouge :
4968 Post-approval Study
Baton Rouge :
nEw3 Post-approval Study
Covington :
nEw3 Post-approval Study
Maryland
Baltimore : Johns Hopkins Hospital
Cardiac Arrest Recovery EEG Study
Baltimore : Johns Hopkins Bayview Medical Center
Cardiac Arrest Recovery EEG Study
Baltimore : Johns Hopkins Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Baltimore : University of Maryland Medical Center, EP Lab, Rm. N3W77
Imaging With a Radio Tracer to Guide VT Ablations
Salisbury :
4968 Post-approval Study
View More »
Salisbury :
nEw3 Post-approval Study
Silver Spring :
4968 Post-approval Study
Silver Spring :
nEw3 Post-approval Study
Takoma Park :
nEw3 Post-approval Study
Towson :
4968 Post-approval Study
Towson :
nEw3 Post-approval Study
Massachusetts
Boston : Brigham and Womens Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Boston : Massachusetts General Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Worcester :
nEw3 Post-approval Study
Michigan
Grand blanc :
4968 Post-approval Study
Lansing :
nEw3 Post-approval Study
Marquette :
4968 Post-approval Study
Marquette :
nEw3 Post-approval Study
Saginaw :
4968 Post-approval Study
View More »
Saginaw :
nEw3 Post-approval Study
Southfield :
4968 Post-approval Study
Ypsilanti : Saint Joseph Mercy Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Ypsilanti :
nEw3 Post-approval Study
Minnesota
Coon Rapids :
nEw3 Post-approval Study
Minneapolis : Minneapolis V.A. Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Minneapolis :
nEw3 Post-approval Study
Robbinsdale :
4968 Post-approval Study
Robbinsdale :
nEw3 Post-approval Study
View More »
Rochester :
4968 Post-approval Study
Rochester : Mayo Clinic Rochester Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Rochester :
nEw3 Post-approval Study
Saint Louis Park :
nEw3 Post-approval Study
Saint Paul :
4968 Post-approval Study
Saint Paul :
nEw3 Post-approval Study
St. Louis Park : Park Nicollet Methodist Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Missouri
Columbia :
nEw3 Post-approval Study
Kansas City :
4968 Post-approval Study
Kansas City :
nEw3 Post-approval Study
St. Louis : Saint John's Mercy Heart Health Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Washington :
nEw3 Post-approval Study
Montana
Missoula : The International Heart Institute of Montana Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
New Hampshire
Lebanon :
4968 Post-approval Study
Lebanon :
nEw3 Post-approval Study
New Jersey
Brown Mills :
4968 Post-approval Study
Brown Mills :
nEw3 Post-approval Study
Camden : Cooper University Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Hackensack : Hackensack University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Newark :
4968 Post-approval Study
View More »
News Brunswick : Robert Wood Johnson University Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Ocean :
4968 Post-approval Study
Ocean :
nEw3 Post-approval Study
Parlin :
4968 Post-approval Study
Parlin :
nEw3 Post-approval Study
West Orange :
4968 Post-approval Study
West Orange :
nEw3 Post-approval Study
New Mexico
Albuquerque :
4968 Post-approval Study
Albuquerque :
nEw3 Post-approval Study
New York
Albany : Albany Associates in Cardiology Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Bronx : Montefiore Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Garden City :
nEw3 Post-approval Study
Henderson :
nEw3 Post-approval Study
Huntington :
nEw3 Post-approval Study
View More »
Mineola :
4968 Post-approval Study
New York : Columbia University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
New York : New York University Langone Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Poughkeepsie :
nEw3 Post-approval Study
Rochester :
4968 Post-approval Study
Rochester :
nEw3 Post-approval Study
Stony Brook : Stony Brook University Hospital and Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Utica :
nEw3 Post-approval Study
North Carolina
Raleigh : Rex Healthcare
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination (ISIS-ICD)
View More »
Chapel Hill : University of North Carolina at Chapel Hill Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Charlotte : The Sanger Clinic, PA Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Durham : Duke University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Durham :
nEw3 Post-approval Study
Greensboro :
4968 Post-approval Study
Greensboro :
nEw3 Post-approval Study
Hickory :
4968 Post-approval Study
Raleigh :
nEw3 Post-approval Study
Winston Salem :
nEw3 Post-approval Study
Winston-Salem : Wake Forest University Health Sciences Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
North Dakota
Fargo :
nEw3 Post-approval Study
Ohio
Akron :
nEw3 Post-approval Study
Cincinnati :
4968 Post-approval Study
Cincinnati : Medisync Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Cincinnati : University of Cincinnati Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Cincinnati :
nEw3 Post-approval Study
View More »
Cleveland :
4968 Post-approval Study
Cleveland : Cleveland Clinic Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Cleveland :
nEw3 Post-approval Study
Columbus :
4968 Post-approval Study
Columbus : Ohio State University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Columbus :
nEw3 Post-approval Study
Toledo :
4968 Post-approval Study
Toledo : University of Toledo Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Toledo :
nEw3 Post-approval Study
Oklahoma
Tulsa : Oklahoma Heart Institute Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Oregon
Portland :
4968 Post-approval Study
Portland : Providence Saint Vincent Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Portland : Oregon Health and Science University Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Portland :
nEw3 Post-approval Study
Pennsylvania
Danville : Geisinger Wyoming Valley Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Doylestown :
4968 Post-approval Study
Erie :
nEw3 Post-approval Study
Hershey : Penn State University Cardiovascular Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Lancaster :
4968 Post-approval Study
View More »
Lancaster :
nEw3 Post-approval Study
Philadelphia : Thomas Jefferson University
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Philadelphia : University of Pennsylvania Health System Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Philadelphia : Drexel University College of Medicine Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Pittsburgh : V.A. Pittsburgh Healthcare System Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Sayre :
4968 Post-approval Study
Sayre :
nEw3 Post-approval Study
Wynnewood : Lankenau Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
South Carolina
Charleston :
nEw3 Post-approval Study
Columbia :
4968 Post-approval Study
Columbia :
nEw3 Post-approval Study
Florence :
4968 Post-approval Study
Florence :
nEw3 Post-approval Study
South Dakota
Sioux Falls :
4968 Post-approval Study
Sioux Falls :
nEw3 Post-approval Study
Tennessee
Chattanooga :
4968 Post-approval Study
Chattanooga :
nEw3 Post-approval Study
Germantown :
4968 Post-approval Study
Germantown :
nEw3 Post-approval Study
Kingsport :
nEw3 Post-approval Study
View More »
Memphis :
4968 Post-approval Study
Nashville :
4968 Post-approval Study
Nashville : Vanderbilt University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Nashville :
nEw3 Post-approval Study
Texas
Amarillo :
4968 Post-approval Study
Austin :
4968 Post-approval Study
Austin : Texas Cardiac Arrhythmia Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Austin :
nEw3 Post-approval Study
Dallas :
4968 Post-approval Study
View More »
Dallas : Baylor Heart and Vascular Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Dallas :
nEw3 Post-approval Study
Fort Worth :
4968 Post-approval Study
Fort Worth : Baylor All Saints Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Fort Worth :
nEw3 Post-approval Study
Houston :
4968 Post-approval Study
Houston : University of Texas Health Science Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Houston :
nEw3 Post-approval Study
Plano : The Heart Hospital Baylor Plano Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Plano :
nEw3 Post-approval Study
San Antonio :
4968 Post-approval Study
San Antonio : South Texas Cardiovascular Consultants Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
San Antonio :
nEw3 Post-approval Study
Temple : Scott and White Memorial Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
The Woodlands :
4968 Post-approval Study
The Woodlands :
nEw3 Post-approval Study
Utah
Salt Lake City : Intermountain Medical Center-LDS Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Vermont
Burlington :
4968 Post-approval Study
Burlington :
nEw3 Post-approval Study
Virginia
Charlottesville : University of Virginia Health System Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Chesapeake :
4968 Post-approval Study
Chesapeake :
nEw3 Post-approval Study
Fairfax :
4968 Post-approval Study
Fairfax :
nEw3 Post-approval Study
View More »
Norfolk : Sentara Norfolk General Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Richmond : Virginia Commonwealth University Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Washington
Olympia :
4968 Post-approval Study
Olympia :
nEw3 Post-approval Study
Seattle : Swedish Medical Center - Providence Campus Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Seattle : University of Washington Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Spokane :
4968 Post-approval Study
View More »
Spokane :
nEw3 Post-approval Study
Tacoma : Cardiac Study Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Tacoma :
nEw3 Post-approval Study
Wisconsin
Madison :
4968 Post-approval Study
Madison :
nEw3 Post-approval Study
Milwaukee :
4968 Post-approval Study
Milwaukee : Medical College of Wisconsin at Froedtert Memorial Luthern Hospital Clinics - Neurology
Cardiac Arrest Recovery EEG Study
Milwaukee : Aurora Saint Lukes Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
View More »
Milwaukee :
nEw3 Post-approval Study
Australia
Adelaide : Royal Adelaide Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Bedford Park :
4968 Post-approval Study
Parkville : Royal Adelaide Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Parkville : Royal Melbourne Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Westmead : Westmead Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Austria
Linz :
4968 Post-approval Study
Linz :
nEw3 Post-approval Study
Linz :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Vienna :
4968 Post-approval Study
Belgium
Braine l'Alleud : C.H.I.R.E.C. - Site de Braine la Alleud
PANORAMA Observational Study
Brasschaat : A.Z. Klina
PANORAMA Observational Study
Hasselt :
4968 Post-approval Study
Hasselt :
nEw3 Post-approval Study
Hasselt :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
View More »
Mortsel : St. Vincentius-Campus St. Jozef
PANORAMA Observational Study
Namur : Centre de Medecine Cardiologique
PANORAMA Observational Study
Tournai : Centre Hosp. Régional du Tournaisis- Site Hopital
PANORAMA Observational Study
Tournai : Hôpital Notre Dame de Tournai
PANORAMA Observational Study
Brazil
Sao Paulo : Hospital Sao Paulo Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Canada
Calgary :
4968 Post-approval Study
Calgary : University of Calgary Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Calgary :
nEw3 Post-approval Study
Hamilton :
4968 Post-approval Study
Kingston :
nEw3 Post-approval Study
View More »
Montreal :
4968 Post-approval Study
Montreal :
nEw3 Post-approval Study
Ottawa :
4968 Post-approval Study
Ottawa :
nEw3 Post-approval Study
Regina :
4968 Post-approval Study
Regina :
nEw3 Post-approval Study
Ste-Foy :
4968 Post-approval Study
Toronto :
4968 Post-approval Study
Toronto :
nEw3 Post-approval Study
Vancouver : Saint Pauls Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
China
Beijing : Beijing Anzhen Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Beijing : Fuwai Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Guangzhou : Guangdong Provincial People's Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Nanjing : First Affiliated Hospital of Nanjing Medical University Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Denmark
Copenhagen :
4968 Post-approval Study
Copenhagen :
nEw3 Post-approval Study
Copenhagen :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Former Serbia and Montenegro
France
Marseille :
4968 Post-approval Study
Marseille :
nEw3 Post-approval Study
Marseille :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Nantes :
nEw3 Post-approval Study
Nantes :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Germany
Bad Krozingen : Herz-Zentrum Bad Krozingen
FREEZE Cohort Study
Bad Nauheim : Kerckhoff Klinik Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Bad Nauheim : Kerckhoff-Klinik
FREEZE Cohort Study
Bad Oeynhausen : Herz- und Diabeteszentrum
FREEZE Cohort Study
Berlin : Vivantes Klinikum Am Urban
FREEZE Cohort Study
View More »
Coburg : Klinikum Coburg Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Coburg : Klinikum Coburg
FREEZE Cohort Study
Dresden : Praxisklinik Herz and Gefaesse Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Dresden : Praxisklinik Herz und Gefäße
FREEZE Cohort Study
Frankfurt : CCB - Cardioaniologisches Centrum Bethanien Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Frankfurt : Cardioangiologisches Centrum Bethanien - CCB
FREEZE Cohort Study
Hamburg : Asklepios Klinik St. Georg Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Hamburg : Universitares Herrzentrum Hamburg Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Hamburg : Asklepios Klinik Barmbek Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Hamburg : Universitäres Herzzentrum
FREEZE Cohort Study
Hamburg : Asklepios Klinik St. Georg
FREEZE Cohort Study
Hildesheim : Städt. Klinikum Hildesheim
FREEZE Cohort Study
Homburg/Saar :
4968 Post-approval Study
Homburg/Saar :
nEw3 Post-approval Study
Homburg/Saar :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Kaiserslautern : Westpfalz-Klinikum GmbH
FREEZE Cohort Study
Karlsruhe : Saint Vincentius-Kliniken Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Leipzig : Herzzentrum Leipzig Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Mannheim : University Hospital of Mannheim Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
München : Isar Herzzentrum München
FREEZE Cohort Study
München : Krankenhaus München Bogenhausen
FREEZE Cohort Study
Münster : Universitätsklinikum Münster
FREEZE Cohort Study
Rostock : Universitat Rostock Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
India
Italy
Catanzaro :
4968 Post-approval Study
Milan : Policlinico San Donato Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Reggio Emilia :
4968 Post-approval Study
Reggio Emilia :
nEw3 Post-approval Study
Reggio Emilia :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
View More »
Udine :
4968 Post-approval Study
Udine :
nEw3 Post-approval Study
Udine :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Korea, Republic of
Seoul : Korea University Anam Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Seoul : Asan Medical Center Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Soeul : Yonsei University Severance Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Kuwait
Netherlands
Eindhoven :
4968 Post-approval Study
Eindhoven :
nEw3 Post-approval Study
Eindhoven :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Rotterdam :
4968 Post-approval Study
Rotterdam :
nEw3 Post-approval Study
View More »
Rotterdam :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Russian Federation
Saudi Arabia
Serbia
Belgrade :
nEw3 Post-approval Study
Belgrade :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Spain
Valencia :
4968 Post-approval Study
Sweden
Skovde :
4968 Post-approval Study
Skovde :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Skövde :
nEw3 Post-approval Study
Switzerland
Zurich :
4968 Post-approval Study
Zurich :
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products
Zürich :
nEw3 Post-approval Study
United Kingdom
Cambridge : Papworth Hospital NHS Foundation Trust Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Glasgow : Golden Jubilee Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
London : Saint Thomas Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
London : Saint Bartholomew's Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
London : Saint George's Hospital Medical School Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
View More »
London : Saint Mary's Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
London : The Heart Hospital Updated
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
